Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by subaru1ion Jan 27, 2024 3:32pm
91 Views
Post# 35848741

RE:RE:Curaleaf CEO said DEA has until end of April 2024 to

RE:RE:Curaleaf CEO said DEA has until end of April 2024 to Thank you.  The request came from the White House, descheduling is a hot topic issue in the U.S. with over 65% of the population in favor of full legalization as well.   If the DEA drags their feet too long, before the election, Biden as President has the full authority to appoint a NEW head to the DEA so that it WILL be rescheduled ONE WAY OR ANOTHER!!!

You have the White House, the FDA, and the NIH all requesting it.   If the head of the DEA wants to perserve her political career in Washington, she will make sure that the President's request is met because now the DEA has more than enough scientific evidence AND clinical trial evidence not to deschedule it.   Polical jockeying would spell political suicide at the DEA. 

I don't why the CEO of CuraLeaf said the DEA has until the end of April 2024 in the video link posted by 1hottechwoman....does he higer level visibility?  He also mentioned institutions are warming up again to cannabis stocks.  


<< Previous
Bullboard Posts
Next >>